Menu
 
Research menu
Jump to menu

Publications:  Dr Linda Hammond

Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD, Hitman GA, McDermott MF et al.(2005). Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis Rheum vol. 52, (9) 2906-2916.
10.1002/art.21268
Perera WR, Hammond LJ, Hurst JR, Wilkinson TMA, Donaldson GC, Wedzicha JA (2004). Peripheral blood T cell subsets in stable COPD and at exacerbation. THORAX. vol. 59, 58-59.
Perera WR, Hammond LJ, Hurst JR, Wilkinson TMA, Donaldson GC, Wedzicha JA (2004). Peripheral blood neutrophils in stable COPD and at exacerbation. THORAX. vol. 59, 58-58.
Stojanov S, Lohse P, McDermott MF, Renner ED, Kery A, Mirakian R, Hammond LJ, Aganna E et al.(2004). Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q. RHEUMATOLOGY vol. 43, (4) 526-527.
10.1093/rheumatology/keh066
Khurrum SF, Wu Z, Olivera DBG, Hammond L, Biro PA, Mirakian R (2003). Inhibition of Il4 production in a rat mast cell line by antisense technology. CLINICAL AND EXPERIMENTAL ALLERGY. vol. 33, 1467-1467.
Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HKP, Mischung C, Kusuhara K et al.(2003). Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum vol. 48, (9) 2632-2644.
10.1002/art.11215
Arkwright PD, McDermottt MF, Houten SM, Frenkel J, Waterhan HR, Aganna E, Hammond LJ, Mirakian RM et al.(2002). Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. CLIN EXP IMMUNOL vol. 130, (3) 484-488.
10.1046/j.1365-2249.2002.02002.x
Khurrum SF, Hammond L, Biro PA, Mirakian R (2002). Antisense IL-4 constructs as possible therapeutic tools for the treatment of asthma and other allergic diseases. ALLERGY. vol. 57, 13-14.
Mirakian R, Nye K, Palazzo FF, Goode AW, Hammond LJ(2002). Methods for detecting apoptosis in thyroid diseases. J IMMUNOL METHODS vol. 265, (1-2) 161-175.
10.1016/s0022-1759(02)00078-9
Hammond LJ, Palazzo FF, Shattock M, Goode AW, Mirakian R(2001). Thyrocyte targets and effectors of autoimmunity: A role for death receptors?. THYROID vol. 11, (10) 919-927.
10.1089/105072501753210975
Palazzo FF, Hammond LJ, Goode AW, Mirakian R(2001). Role of key caspases and cytochrome c in thyrocyte apoptosis. BRIT J SURG vol. 88, (9) 1277-1277.
Palazzo FF, Hammond LJ, Mirakian R, Goode AW(2001). Caspase and cytochrome C induction in thyrocyte apoptosis. BRIT J SURG vol. 88, 32-32.
Mirakian R, Hammond LJ, Bottazzo GF(2001). T(H)1 and T(H)2 cytokine control of thyrocyte survival in thyroid autoimmunity. NAT IMMUNOL vol. 2, (5) 371-371.
10.1038/87661
Return to top